ACS Releases Guidelines for HPV Vaccination
Cox JT et al. - The American Cancer Society (ACS) guideline for the early detection of cervical cancer was last reviewed and updated in 2002. Since then, two vaccines against the most common cancer-causing types of human papillomavirus (HPV) have been developed and tested in clinical trials (i.e., quadrivalent HPV vaccine [Gardasil] and bivalent HPV vaccine [Cervarix], not yet approved by the U.S. Food and Drug Administration [FDA]). [more...]
|
|
|
